全文获取类型
收费全文 | 287篇 |
免费 | 27篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 4篇 |
妇产科学 | 1篇 |
基础医学 | 27篇 |
临床医学 | 27篇 |
内科学 | 109篇 |
皮肤病学 | 19篇 |
神经病学 | 30篇 |
特种医学 | 6篇 |
外科学 | 24篇 |
一般理论 | 1篇 |
预防医学 | 32篇 |
眼科学 | 3篇 |
药学 | 7篇 |
肿瘤学 | 21篇 |
出版年
2024年 | 2篇 |
2023年 | 1篇 |
2022年 | 10篇 |
2021年 | 13篇 |
2020年 | 11篇 |
2019年 | 23篇 |
2018年 | 21篇 |
2017年 | 14篇 |
2016年 | 18篇 |
2015年 | 10篇 |
2014年 | 18篇 |
2013年 | 24篇 |
2012年 | 27篇 |
2011年 | 20篇 |
2010年 | 12篇 |
2009年 | 3篇 |
2008年 | 13篇 |
2007年 | 13篇 |
2006年 | 9篇 |
2005年 | 10篇 |
2004年 | 3篇 |
2003年 | 4篇 |
2002年 | 1篇 |
2000年 | 1篇 |
1997年 | 1篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1987年 | 2篇 |
1984年 | 4篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1972年 | 4篇 |
1971年 | 1篇 |
1970年 | 1篇 |
1969年 | 3篇 |
1968年 | 1篇 |
1967年 | 1篇 |
1966年 | 3篇 |
1965年 | 1篇 |
排序方式: 共有314条查询结果,搜索用时 0 毫秒
311.
312.
Aneurysm of the Pulmonary Artery,a Systematic Review and Critical Analysis of Current Literature 下载免费PDF全文
313.
mTOR inhibitor‐induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithm 下载免费PDF全文
Annelieke E.C.A.B. Willemsen Jan C. Grutters Winald R. Gerritsen Nielka P. van Erp Carla M.L. van Herpen Jolien Tol 《International journal of cancer. Journal international du cancer》2016,138(10):2312-2321
Mammalian target of rapamycin inhibitors (mTORi) have clinically significant activity against various malignancies, such as renal cell carcinoma and breast cancer, but their use can be complicated by several toxicities. Interstitial lung disease (ILD) is an adverse event of particular importance. Mostly, mTORi‐induced ILD remains asymptomatic or mildly symptomatic, but it can also lead to severe morbidity and even mortality. Therefore, careful diagnosis and management of ILD is warranted. The reported incidence of mTORi‐induced ILD varies widely because of a lack of uniform diagnostic criteria and active surveillance. Because of the nonspecific clinical features, a broad differential diagnosis that includes (opportunistic) infections should be considered in case of suspicion of mTORi‐induced ILD. The exact mechanism or interplay of mechanisms leading to the development of ILD remains to be defined. Suggested mechanisms are either a direct toxic effect or immune‐mediated mechanisms, considering mTOR inhibitors have several effects on the immune system. The clinical course of ILD varies widely and is difficult to predict. Consequently, the discrimination between when mTOR inhibitors can be continued safely and when discontinuation is indicated is challenging. In this review, we give a comprehensive review of the incidence, clinical presentation and pathophysiology of mTORi‐induced ILD in cancer patients. We present newly developed diagnostic criteria for ILD, which include clinical symptoms as well as basic pulmonary function tests and radiological abnormalities. In conjunction with these diagnostic criteria, we provide a detailed and easily applicable clinical management algorithm. 相似文献
314.